UNSPSC 41122107: Tissue culture coated plates or dishes or inserts

UNSPSC 41122107 Tissue culture coated plates or dishes or inserts is a Commodity code that sees minimal alignment with recent state and local procurement activity. The source contains no solicitations for tissue culture plates, culture dishes, or insert products; instead, the recent opportunities reflect laboratory reagents, equipment, and testing services across genomic surveillance, wastewater monitoring, newborn screening, forensic evidence processing, and water quality analysis. The code nominally describes cell culture consumables, but the posted opportunities show demand for synthetic viral controls, oligonucleotide reagents, dPCR instruments and reagents, high-throughput genomics systems, magnetic hydrogel particles, vacuum manifolds, microplate sealers, and forensic consumables—none of which fall within tissue culture plate scope.

The issuing bodies pursuing laboratory work under related codes span state health departments (Colorado Department of Public Health and Environment, Texas General Land Office), municipal utilities and public health agencies (City of Palm Bay, County of Santa Clara), state transportation departments (Texas Department of Transportation), and the State of California across multiple procurement channels. Colorado CDPHE appears repeatedly with sole-source reagent and equipment procurements, while California issues competitive bids for forensic and laboratory supplies. Geographic concentration is heaviest in Colorado (wastewater surveillance, newborn screening, genomic sequencing programs) and California (forensic consumables, laboratory equipment), with activity also in Texas (water quality, transportation lab equipment) and Florida (municipal water and wastewater testing). Representative recent opportunities include the Texas General Land Office's IFB 7643-LP for water sample collection and analysis services with an April 10, 2026 deadline, Colorado CDPHE's sole-source procurements for Qiagen wastewater reagents ($3.14 million, May 28, 2026), Standard BioTools genomic systems ($2.3 million plus $1 million in reagents, May 28, 2026), Ceres Nanosciences microbiome particles ($3.5 million, May 22, 2026), Twist Bioscience synthetic viral controls ($2.3 million, May 22, 2026), and Integrated DNA Technologies oligonucleotide reagents ($1.7 million modification, April 14, 2026). Activity under the tissue culture code itself is not present in the recent opportunity set.